The Role of Helicobacter Pylori CagA in Gastric Carcinogenesis

Overview

Journal Int J Hematol

Specialty Hematology

Date 2006 Nov 23

PMID 17118755

Citations 31

Authors

Masanori Hatakeyama

Affiliations

Soon will be listed here.

Abstract

Gastric carcinoma is the second most common cause of cancer-related deaths in the world, accounting for more than 400,000 deaths each year. Infection with cagA-positive Helicobacter pylori plays a pivotal role in the development of gastric adenocarcinoma. The cagA gene product CagA is directly delivered into gastric epithelial cells via the type IV secretion system. Following membrane localization and subsequent tyrosine phosphorylation by Src family kinases, CagA interacts with a variety of host cell proteins that are involved in the regulation of cell growth and motility in both phosphorylation-dependent and -independent manners. Of special interest is the interaction of CagA with the SH2 domain-containing tyrosine phosphatase SHP-2, gain-of-function mutations of which have recently been found in human malignancies. CagA binds to and activates SHP-2 in a tyrosine phosphorylation-dependent manner, thereby provoking abnormal activation of Erk MAP kinase while inducing elevated cell motility. Perturbation of SHP-2 and other signaling molecules by H pylori CagA may predispose cells to accumulate multiple genetic and epigenetic changes that promote multistep gastric carcinogenesis. Intriguingly, the structural polymorphism of CagA accounts for the differences in pathophysiological activity of individual CagA proteins, raising the possibility of subclassification of H pylori strains into benign and malignant strains.

Citing Articles

Peroxiporins and Oxidative Stress: Promising Targets to Tackle Inflammation and Cancer.

da Silva I, Mlinaric M, Lourenco A, Perez-Garcia O, cipak Gasparovic A, Soveral G Int J Mol Sci. 2024; 25(15).

PMID: 39125952 PMC: 11313477. DOI: 10.3390/ijms25158381.

From infection to gastric cancer: Current evidence on the immune response.

Lima de Souza Goncalves V, Santos M, Silva Luz M, Marques H, de Brito B, da Silva F World J Clin Oncol. 2022; 13(3):186-199.

PMID: 35433296 PMC: 8966509. DOI: 10.5306/wjco.v13.i3.186.

Pathogenicity Islands and Cysteine Proteases in Role of Coinfection and Pathogenesis.

Tilahun M, Gedefie A, Belayhun C, Sahle Z, Abera A Infect Drug Resist. 2022; 15:21-34.

PMID: 35023934 PMC: 8747529. DOI: 10.2147/IDR.S346705.

Molecular pathology underlying the robustness of cancer stem cells.

Yoshida G, Saya H Regen Ther. 2021; 17:38-50.

PMID: 33869685 PMC: 8024885. DOI: 10.1016/j.reth.2021.02.002.

Trends in Symbiont-Induced Host Cellular Differentiation.

Russell S, Castillo J Results Probl Cell Differ. 2020; 69:137-176.

PMID: 33263871 PMC: 8025664. DOI: 10.1007/978-3-030-51849-3_5.

References

Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C . Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell. 2002; 10(4):745-55. DOI: 10.1016/s1097-2765(02)00681-0. View

Neel B, Gu H, Pao L . The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003; 28(6):284-93. DOI: 10.1016/S0968-0004(03)00091-4. View

Kuipers E, Perez-Perez G, Meuwissen S, Blaser M . Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995; 87(23):1777-80. DOI: 10.1093/jnci/87.23.1777. View

Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut P . Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol. 2001; 2(2):155-64. DOI: 10.1046/j.1462-5822.2000.00043.x. View

Selbach M, Moese S, Hauck C, Meyer T, Backert S . Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem. 2002; 277(9):6775-8. DOI: 10.1074/jbc.C100754200. View

Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P . E-cadherin germline mutations in familial gastric cancer. Nature. 1998; 392(6674):402-5. DOI: 10.1038/32918. View

Yamazaki S, Yamakawa A, Ito Y, Ohtani M, Higashi H, Hatakeyama M . The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis. 2003; 187(2):334-7. DOI: 10.1086/367807. View

Hatakeyama M . Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004; 4(9):688-94. DOI: 10.1038/nrc1433. View

Tartaglia M, Niemeyer C, Fragale A, Song X, Buechner J, Jung A . Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003; 34(2):148-50. DOI: 10.1038/ng1156. View

10.

Brandt S, Kwok T, Hartig R, Konig W, Backert S . NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A. 2005; 102(26):9300-5. PMC: 1166591. DOI: 10.1073/pnas.0409873102. View

11.

Nomura A, STEMMERMANN G, Chyou P, Kato I, Perez-Perez G, Blaser M . Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991; 325(16):1132-6. DOI: 10.1056/NEJM199110173251604. View

12.

Hatakeyama M . Helicobacter pylori CagA--a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect. 2003; 5(2):143-50. DOI: 10.1016/s1286-4579(02)00085-0. View

13.

Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H . Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis. 2004; 189(5):820-7. DOI: 10.1086/381782. View

14.

Wong B, Lam S, Wong W, Chen J, Zheng T, Feng R . Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004; 291(2):187-94. DOI: 10.1001/jama.291.2.187. View

15.

Azuma T, Ohtani M, Yamazaki Y, Higashi H, Hatakeyama M . Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology. 2004; 126(7):1926-7. DOI: 10.1053/j.gastro.2004.04.049. View

16.

Blaser M, Perez-Perez G, Kleanthous H, Cover T, Peek R, Chyou P . Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995; 55(10):2111-5. View

17.

Bentires-Alj M, Paez J, David F, Keilhack H, Halmos B, Naoki K . Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 2004; 64(24):8816-20. DOI: 10.1158/0008-5472.CAN-04-1923. View

18.

Churin Y, Al-Ghoul L, Kepp O, Meyer T, Birchmeier W, Naumann M . Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol. 2003; 161(2):249-55. PMC: 2172921. DOI: 10.1083/jcb.200208039. View

19.

Amieva M, Vogelmann R, Covacci A, Tompkins L, Nelson W, Falkow S . Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science. 2003; 300(5624):1430-4. PMC: 3369828. DOI: 10.1126/science.1081919. View

20.

Hirata Y, Maeda S, Mitsuno Y, Tateishi K, Yanai A, Akanuma M . Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology. 2002; 123(6):1962-71. DOI: 10.1053/gast.2002.37044. View